DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Olinvyk is a drug marketed by Trevena and is included in one NDA. There are three patents protecting this drug.
This drug has forty patent family members in twenty-three countries.
The generic ingredient in OLINVYK is oliceridine. Additional details are available on the oliceridine profile page.
Olinvyk will be eligible for patent challenges on October 30, 2024. This date may extended up to six months if a pediatric exclusivity extension is applied to the drug's patents.
By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be March 23, 2032. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
DrugPatentWatch® Estimated Generic Entry Opportunity Date for OLINVYK
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Trevena||OLINVYK||oliceridine||SOLUTION;INTRAVENOUS||210730-001||Oct 30, 2020||RX||Yes||Yes||Get Started Free||Get Started Free||Y||Get Started Free|
|Trevena||OLINVYK||oliceridine||SOLUTION;INTRAVENOUS||210730-002||Oct 30, 2020||RX||Yes||Yes||Get Started Free||Get Started Free||Y||Y||Get Started Free|
|Trevena||OLINVYK||oliceridine||SOLUTION;INTRAVENOUS||210730-001||Oct 30, 2020||RX||Yes||Yes||Get Started Free||Get Started Free||Get Started Free|
|Trevena||OLINVYK||oliceridine||SOLUTION;INTRAVENOUS||210730-003||Oct 30, 2020||RX||Yes||Yes||Get Started Free||Get Started Free||Get Started Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|